Safety Syringe Market

Safety Syringe Market Outlook from 2024 to 2034

The global safety syringe market was valued at USD 7,416.3 million in 2023 and is expected to reach USD 12,054.3 million in 2034. The market is expected to surge at a CAGR of 4.5% through 2034. It is anticipated to attain a value of around USD 7,736.2 million in 2024.

Attributes	Key Insights
Safety Syringe Market Size in 2023	USD 7,416.3 million
Estimated Safety Syringe Market Value (2024)	USD 7,736.2 million
Forecast Safety Syringe Market Revenue (2034)	USD 12,054.3 million
Value-based CAGR (2024 to 2034)	4.5%

Syringes are widely utilized in several medical settings, including hospitals and clinics, for vaccines, insulin administration, and other vital pharmacological therapies. Their uniform design allows healthcare service providers to offer consistent and controlled drug distribution, which improves patient safety and treatment efficacy.

Safety syringes are made with mechanisms that either retract, shield, or deactivate the needle after use to reduce the possibility of unintentional needlestick injuries. These syringes are frequently used in medical settings, such as blood collection, medication delivery, and immunizations.

The market for safety syringes is primarily driven by strict regulatory demands that encourage the use of safety devices, growing worries about the spread of blood-borne illnesses, and growing awareness of needlestick injuries. Continuous technological innovations and developments would aid in the creation of safer, more user-friendly syringes.

Global health initiatives such as immunization campaigns and efforts to combat infectious illnesses influence the need for safe syringes in the market. In the safety syringe industry, trends such as the growing use of self-administration tools, the demand for disposable syringes, and partnerships between significant competitors are driving growth.

2019 to 2023 Safety Syringe Market Outlook Vs. 2024 to 2034 Forecast

The global market for systematic syringes grew at a CAGR of 4.3% from 2019 to 2023. Several factors, including a greater understanding of the importance of needle stick injury prevention and healthcare worker safety, can be responsible for the rising sales of safety syringes. Healthcare workers who suffer needlestick injuries have a serious risk of contracting bloodborne infections like HIV, hepatitis B, and hepatitis C.

Safety syringes have become an essential device due to the healthcare industry's active search for ways to improve safety precautions. The healthcare industry's growing emphasis on safety at work standards and regulations is one of the key factors driving sales growth.

The usage of safety syringes has also increased due to rising awareness of infectious diseases, specifically in global health emergencies. Notably, the COVID-19 pandemic has highlighted the need for infection control procedures, compelling healthcare professionals to invest in safer medical equipment, such as syringes with enhanced security features.

Technological developments have also resulted in innovative syringe safety features, like automatic safety shields and retractable needles. These characteristics increase the general effectiveness and accessibility of healthcare environments while reducing the probability of needlestick injuries.

Considering the increasing demand for minimally invasive surgeries, technological advancements, and increased awareness of infectious diseases, the growth of safety syringes is anticipated. The global safety syringe market is expected to propel at a CAGR of 4.5% over the forecast period.

Overview of Key Opportunities Paving Global Systematic Syringe Market Growth

Increasing the number of internet users and raising awareness regarding e-commerce for healthcare products are changing the scenario of distribution channels. Several manufacturers are selling their products through e-commerce websites at the country level.

A handful of e-commerce websites strongly focus on disposable products only. Due to the growing usage of online sales, the growth through online sales is increasing and creating opportunities for the market.

Asia Pacific, Latin America, and the Middle East are the emerging markets in the world. Insulin syringes present a higher opportunity for safe syringes for regions with the leading population and diabetic rate in the world.

The healthcare infrastructure is developing with increasing funding and investment in research & development and technology. Hence, the demand for precise and standardized medical equipment is increasing.

Systematic syringes, with their precision in medicine administration, play an essential role in ensuring effective medication delivery. Rising healthcare investments make modern medical tools more affordable, ultimately creating a favorable environment for the market growth of safe syringes.

Overview of Restrictive Factors for the Systematic Syringe Market

The unauthorized use of safety syringes for illegal purposes is a severe problem when such products are misused. Safety syringe sales for their intended medical uses can drop as a result of unethical users using this product for non-medical purposes, such as the injection of illegal narcotics.

The improper use of safety syringes contradicts the intended usage of these instruments and puts the general public's health at risk. The possibility of needle sharing among drug addicts increases the likelihood of spreading bloodborne pathogens like hepatitis and HIV.

They would add to a more significant public health emergency. Incorrect application of safety syringes has two problems: it reduces the market for appropriate medical usage and makes infectious disease transmission in communities harder. Factors such as the availability of safe syringes in the illegal marketplace and unethical usage of safe syringes could be barriers to the growth of the safe syringe market.

Safety Syringe Market Trends

• Safety syringe use has increased as the public's awareness of needlestick injuries and the desire to prevent them grows.
• Using connection features and electronic technologies to track and monitor data.
• A strong focus on preventing occupational dangers for healthcare personnel has led to a rise in the use of safety syringes in clinics and hospitals.
• The need for safety syringes with user-friendly features has surged due to the growing interest in patients administering injectable medications independently.

Country-wise Insights

The table below shows the estimated growth rates of the top five countries. India, China, and the United Kingdom are set to record higher CAGRs of 10.5%, 9.5%, and 2.2%, respectively, through 2034.

Countries	Value CAGR
United States	1.5%
China	9.5%
Germany	1.8%
United Kingdom	2.2%
India	10.5%

Rising Number of Minimally Invasive Procedures to Push the United States

The United States contributed as the profitable market, holding a global share of around 32.3% in 2023. The United States syringe market is expected to register a CAGR of 1.5% during the forecast period, owing to the rising number of minimally invasive procedures performed in the country.

There is an increasing need for precise and regulated drug administration as these procedures become increasingly common. Safety syringes are essential to the changing landscape of medical treatments in the United States because of the increased attention to patient safety and the efficacy of medication therapy.

Changing Healthcare System in China to Boost Sales of Safety Syringes by 2034

China is projected to be the most attractive market globally in 2023, accounting for a market share of around 6.3%. Several factors, such as growing awareness of infectious disorders, a rise in healthcare spending, and the increasing prevalence of chronic disorders, are contributing to significant market growth. The need for safety syringes is further driven by the growing focus on preventative care and early intervention as China's healthcare system changes to meet the demands of an aging population.

Growing Technological Advancement to Uplift the United Kingdom’s Market

Like several other nations, the United Kingdom has laws to encourage the use of safe syringes. Manufacturers and healthcare facilities must adhere to safety regulations and recommendations. There has probably been a rise in the use of safety syringes in the United Kingdom due to growing awareness of the dangers of needlestick injuries and the significance of safety for healthcare workers.

In the United Kingdom, healthcare practices are greatly influenced by the National Health Service (NHS). The NHS's deployment of safety syringes can significantly impact market dynamics. The nation's general attitude toward medical innovation is influencing the adoption of safe syringes with cutting-edge features and technologies.

Role of Public Health Campaigns to Shape India’s Market Development

The uptake of safety syringes is impacted by the condition of the healthcare system, including hospitals and clinics in India. Healthcare facilities with adequate equipment are more likely to incorporate safety syringes into their operations. Initiatives and public health campaigns geared toward lowering needlestick injuries and encouraging the use of safety syringes are fueling market expansion.

The COVID-19 pandemic has increased public knowledge of safe measures in healthcare. The pandemic's influence may have impacted the safety of syringe adoption on the order of importance for safety precautions. Government rules, including procurement procedures and reimbursement policies, are further influencing the safety syringe market in India.

Robust Safety Standards and Regulations to Gain Traction in Japan

Manufacturers of safe syringes and other medical devices must adhere to strict regulations in Japan. Adherence to safety standards and regulations is essential for market approval and entry. Safety syringe usage is rising in Japan due to increased knowledge about needlestick injury prevention, workplace safety, and healthcare safety.

Due to its aging population, Japan has a significant demand for healthcare services. Two primary drivers driving the market for safe syringes are the state of healthcare and the requirement for safe injection procedures.

Category-wise Insights

The below section shows the retractable segment dominating by product type. It is expected to thrive at a 4.1% CAGR by 2034. Based on application, the subcutaneous segment is anticipated to hold a dominant share through 2034. It is set to exhibit a CAGR of 3.2% during the forecast period.

Segment	Value CAGR (2024 to 2034)
Subcutaneous (Application)	3.2%
Retractable (Product)	4.1%
Hospitals (End-user)	2.8%
Retail Sales (Distribution Channel)	3.5%

Dominance of Retractables as Products to Continue Through 2034

The retractable segment accounted for a dominant share of 68.2% in 2023. Due to more safety measures than non-retractable safety syringes, retractable syringes usually have more significant sales.

The design of retractable syringes mechanically pulls the needle back into the barrel after use, lowering the possibility of needlestick injuries and stopping the transmission of diseases. Retractable syringes have become more prevalent in healthcare settings due to their safety benefit, which has expanded their adoption.

Demand for Safety Syringes to Remain High in Subcutaneous Application

The subcutaneous segment is leading the market with a share of 65.7% in 2023. In general, subcutaneous injections are less effective and painful than intramuscular injections, which go deeper into the muscle tissue.

Subcutaneous injections involve injecting medications into the fatty tissue just beneath the skin. Because of their smaller size, patients find subcutaneous injections utilizing systematic syringes more manageable.

Several drugs are designed to be administered subcutaneously, which makes it the preferred approach for a handful of therapeutic applications. Subcutaneous application with systematic syringes is more common due to a mix of patient comfort, convenience of administration, and pharmaceutical requirements.

Hospital Segment to Rule over Other End-users in the Market

The hospital segment is a leading end-user of the syringe market, with a 29.8% value share in 2023. The hospital segment leads the periodic syringe sales as the end-user due to the high volume of medical testing.

Safety syringes are necessary in hospitals to ensure proper medicine delivery, patient safety, and therapeutic effectiveness. Hospitals have higher revenues in this market than other end-users, including clinics or research institutions, because of the vital importance of healthcare interventions in these locations.

Competitive Landscape

Leading companies are strategically making acquisitions and developing new products to strengthen their positions. Through acquisitions, businesses can expand their skills, penetrate new markets, and diversify their portfolios.

Ongoing product innovations ensure both innovation and competitiveness at the same time. The dynamic market for safety syringes is promoting growth and sustainability through the ability of key players to meet consumer expectations, adjust to evolving industry trends, and maintain a competitive edge through strategic actions.

For instance,

• In November 2023, Terumo Corporation expanded its portfolio of syringes by launching insulin syringes for patients who require regular insulin injections.
• In September 2023, Sharps Technology acquired InjectEZ specialty copolymer syringe manufacturing facility to strengthen the company's manufacturing capacity and expand its position in the syringe industry.
• In May 2022, Babson Diagnostics and BD (Becton, Dickinson, and Company) announced a strategic partnership to integrate blood. They also announced the expansion of sample collection in new medical facilities.

Scope of the Report

Attribute	Details
Estimated Market Size (2024)	USD 7,736.2 million
Forecast Market Size (2034)	USD 12,054.3 million
Projected Growth Rate (2024 to 2034)	4.5%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	USD million for Value
Key Regions Covered	North America; Latin America; South Asia and Pacific; East Asia; Western Europe; Eastern Europe; Middle East and Africa
Key Countries Covered	United States, Canada, Mexico, Brazil, Chile, the Rest of Latin America, China, Japan, South Korea, India, the Association of Southeast Asian Nations, Australia and New Zealand, the Rest of South Asia and Pacific, Germany, Italy, France, United Kingdom, Spain BENELUX, Nordic Countries, Rest of Western Europe, Russia, Hungary, Poland, Rest of Eastern Europe, Saudi Arabia, Türkiye, South Africa, Other African Union, Rest of Middle East and Africa
Key Segments Covered	Product, Application, Distribution Channel, End-user, and Region
Key Companies Profiled	Becton; Dickinson and Company; AdvaCare Pharma; Cardinal Health Inc.; DMC Medical Ltd.; Duopross Meditech Corp.; Haiou Medical; Kendall Healthcare; Lifelong Meditech (Group); Medicina (HMC Group); Medline Industries; Nipro Corporation; Numedico; Nemera; Retractable Technologies, Inc.; Revolutions Medical Corporation; Smith’s Medical, Inc. (ICU Medical, Inc.); Sol-Millennium Medical Group; Terumo Corporation; UltiMed, Inc. (Ulticare); Unilife Corporation; B. Braun Melsungen AG; Fresenius Kabi AG; West Pharmaceutical Services, Inc.
Report Coverage	Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities, Trends, Market Dynamics and Challenges, Strategic Growth Initiatives

Safety Syringe Market Segmentation by Category

By Product:

• Retractable
  • Manual Retractable Safety Syringes
  • Automatic Retractable Safety Syringes
• Non-retractable
  • Sliding Needle Cover Syringes
  • Sheathing Tube Syringes
  • Hinged Needle Cover Syringes

By Application:

• Subcutaneous
• Intramuscular

By Distribution Channel:

• Direct to Customer (DTC)
• Retail Sales
  • Retail Pharmacies
  • Drug Stores
• Online Pharmacies

By End-user:

• Hospitals
• Ambulatory Surgical Centers
• Long-term Care Facilities
• Specialty Clinics
• Others

By Region:

• North America
• Latin America
• East Asia
• South Asia and Pacific
• Western Europe
• Eastern Europe
• Middle East and Africa

Frequently Asked Questions

How big was the global market in 2023?

The market was worth USD 7,416.3 million in 2023.

What is the sales forecast for the global market through 2034?

The market is expected to reach USD 12,054.3 million in 2034.

What was the last six year’s growth rate for the safety syringe market?

The global market grew at a CAGR of 4.3% between 2019 and 2023.

What is the United States' outlook for the safety syringe market?

The United States contributed USD 2,393.3 million in 2022.

What is the outlook for the India market?

India is expected to surge at a CAGR of 10.5% by 2034.

Which product segment held the prominent share in 2023?

The retractable segment held a prominent share of 68.2% in 2023.